Evidence map›Paper›PMID 36869049›Full record

ArticleNature communications2023

The dynamic nature of netrin-1 and the structural basis for glycosaminoglycan fragment-induced filament formation.

Markus Meier, Monika Gupta, Serife Akgül, Matthew McDougall, Thomas Imhof, Denise Nikodemus, Raphael Reuten, Aniel Moya-Torres, Vu To, Fraser Ferens and 10 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. The UCMD-CausingHuman mutation · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 7 institutions in 4 countries.

Markus Meier *Department of Chemistry, University of Manitoba, Winnipeg, Canada.ORCID 0000-0003-1068-746X
Monika Gupta *Department of Chemistry, University of Manitoba, Winnipeg, Canada.
Serife Akgül *Center for Biochemistry II, Faculty of Medicine and University Hospital Cologne, University of Cologne, 50931, Cologne, Germany.ORCID 0000-0003-0943-6241
Matthew McDougall *Department of Chemistry, University of Manitoba, Winnipeg, Canada.
Thomas ImhofCenter for Biochemistry II, Faculty of Medicine and University Hospital Cologne, University of Cologne, 50931, Cologne, Germany.
Denise NikodemusFaculty of Biology, Institute of Biology II, Albert Ludwigs University of Freiburg, Freiburg, Germany.
Raphael ReutenInstitute of Experimental and Clinical Pharmacology and Toxicology, Medical Faculty, University of Freiburg, Freiburg, Germany.ORCID 0000-0002-9434-4108
Aniel Moya-TorresDepartment of Chemistry, University of Manitoba, Winnipeg, Canada.
Vu ToDepartment of Chemistry, University of Manitoba, Winnipeg, Canada.
Fraser FerensDepartment of Chemistry, University of Manitoba, Winnipeg, Canada.ORCID 0000-0002-6686-1183
Fabian HeideDepartment of Chemistry, University of Manitoba, Winnipeg, Canada.ORCID 0000-0002-6849-3177
Gay Pauline Padilla-MeierDepartment of Chemistry, University of Manitoba, Winnipeg, Canada.ORCID 0000-0001-8808-9035
Philipp KukuraPhysical and Theoretical Chemistry Laboratory, Department of Chemistry, University of Oxford, South Parks Road, Oxford, OX1 3QZ, UK.ORCID 0000-0003-0136-7704
Wenming HuangMax Planck Institute for Biology of Ageing, Cologne, Germany.
Birgit GerischMax Planck Institute for Biology of Ageing, Cologne, Germany.
Matthias MörgelinColzyx AB, Lund, Sweden.
Kate PooleMax Delbrück Center for Molecular Medicine, Robert Roessle Str 10, Berlin-Buch, Germany.
Adam AntebiMax Planck Institute for Biology of Ageing, Cologne, Germany. aantebi@age.mpg.de.ORCID 0000-0002-7241-3029
Manuel KochCenter for Biochemistry II, Faculty of Medicine and University Hospital Cologne, University of Cologne, 50931, Cologne, Germany. manuel.koch@uni-koeln.de.ORCID 0000-0002-2962-7814
Jörg StetefeldDepartment of Chemistry, University of Manitoba, Winnipeg, Canada. jorg.stetefeld@umanitoba.ca.ORCID 0000-0003-1478-3248
University of Manitoba · CAUniversity of Cologne · DEMax Planck Institute for Biology of Ageing · DEUniversity of Freiburg · DECologne Excellence Cluster on Cellular Stress Responses in Aging Associated Diseases · DEMax Delbrück Center · DEUniversity of Oxford · GB

Funding

CIHR PJT 152935
6 · The paper itself

Abstract

Netrin-1 is a bifunctional chemotropic guidance cue that plays key roles in diverse cellular processes including axon pathfinding, cell migration, adhesion, differentiation, and survival. Here, we present a molecular understanding of netrin-1 mediated interactions with glycosaminoglycan chains of diverse heparan sulfate proteoglycans (HSPGs) and short heparin oligosaccharides. Whereas interactions with HSPGs act as platform to co-localise netrin-1 close to the cell surface, heparin oligosaccharides have a significant impact on the highly dynamic behaviour of netrin-1. Remarkably, the monomer-dimer equilibrium of netrin-1 in solution is abolished in the presence of heparin oligosaccharides and replaced with highly hierarchical and distinct super assemblies leading to unique, yet unknown netrin-1 filament formation. In our integrated approach we provide a molecular mechanism for the filament assembly which opens fresh paths towards a molecular understanding of netrin-1 functions.

Indexed as

GlycosaminoglycansHeparinAxon GuidanceCell DifferentiationHeparan Sulfate ProteoglycansNetrin-1GlycosaminoglycansHeparan Sulfate ProteoglycansHeparinNetrin-1

Identifiers

PMID36869049
PMCPMC9984387
OpenAlexW4323048249

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.